Besides, Garces et al. found that in RDD, immunostain for phospho-ERK overexpression was seen in all MAP2K1-mutated cases of RDD, supporting the activation of MAPK/ERK pathway, but not in KRAS mutated cases. This evidence concerns the gene MAPK1 and sinus histiocytosis with massive lymphadenopathy.